(Q45729784)

15 December 2017

title

Prevalence of diabetes mellitus in renal transplant patients with hepatitis B or C virus infection (English)

1 reference

15 December 2017

Hirakauva EY

1

1 reference

15 December 2017

Ferraz ML

2

1 reference

15 December 2017

Perez RM

3

1 reference

15 December 2017

Ferreira AS

4

1 reference

15 December 2017

Silva AE

5

1 reference

15 December 2017

Hauache O

6

1 reference

15 December 2017

Pestana JO

7

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Transplantation Proceedings

15 December 2017

published in

1 reference

15 December 2017

volume

34

1 reference

15 December 2017

issue

8

1 reference

15 December 2017

page(s)

3220-3222

1 reference

Characteristics of long-term renal transplant survivors

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

Post-transplant diabetes mellitus. The role of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

The mechanism of the carbohydrate intolerance of cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

Association of diabetes mellitus and chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

Increased prevalence of hepatitis C virus antibodies in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

High prevalence of hepatitis C virus infection in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

High incidence of diabetes mellitus after kidney transplant in patients with hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903657-6

7 January 2021

10.1016/S0041-1345(02)03657-6

Identifiers

DOI

1 reference

15 December 2017

1 reference